AQ
Aequus Pharmaceuticals Inc.
AQSZF · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $130.3K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.14x
EV/EBITDA N/A
P/B N/A
Growth
0 /100
Declining Rev. growth 40.07%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 71.46%
Op. margin 62.50%
FCF margin 12.61%
Quality
79 /100
Excellent ROA 334.60%
Asset turnover 4.68x
ROIC 22.38%
Debt
0 /100
High Int. coverage -1.99x
Current ratio 0.03x
Net debt/EBITDA N/A
Stability
23 /100
Unstable Rev. volatility 113.49%
EPS volatility 52.84%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AQSZF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Douglas Glen Janzen
Employees
12
Headquarters
Vancouver